Evaluation and Treatment of Congenital Syphilis: A National Survey of US Pediatric Specialists
- PMID: 39458235
- PMCID: PMC11508399
- DOI: 10.3390/jcm13206280
Evaluation and Treatment of Congenital Syphilis: A National Survey of US Pediatric Specialists
Abstract
Background/Objectives: As congenital syphilis incidence continues to increase yearly in the United States (US), recommendations from government and professional organizations aim to inform effective clinical practice, although it is unclear how closely these recommendations are followed. This study surveyed US pediatric specialists regarding their approach to congenital syphilis diagnosis and treatment to examine decision-making relative to practice guidelines and subspecialty. Methods: US pediatric physicians recruited from subspecialty directories were sent an online survey conducted in March-April 2024. The case-based survey elicited diagnostic and treatment decisions for different case definitions of congenital syphilis (proven or highly probable, possible, and less likely). Results: Among 442 respondents (56.8% women, 74.2% age 40-69, 57.7% 15+ years since training completion), 94.1% chose to evaluate and manage proven or highly probable congenital syphilis as recommended whereas only 45.8% did so for congenital syphilis considered less likely. Diagnostic and treatment decisions by infectious disease specialists and other subspecialists differed across case definitions. Conclusions: Physicians' approaches to congenital syphilis workup and management, including the decision to treat, varied with case presentation where decision-making seemed to diverge from published recommendations and between subspecialists as infection became less likely by case definition.
Keywords: congenital syphilis; infectious diseases; pediatrics.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Similar articles
-
Providing pediatric subspecialty care: A workforce analysis. AAP Committee on Pediatric Workforce Subcommittee on Subspecialty Workforce.Pediatrics. 2000 Dec;106(6):1325-33. doi: 10.1542/peds.106.6.1325. Pediatrics. 2000. PMID: 11099584
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Treatment of infants with reactive syphilis serology, New Jersey: 1992 to 1996.Pediatrics. 1998 Aug;102(2):e27. doi: 10.1542/peds.102.2.e27. Pediatrics. 1998. PMID: 9685473
-
The elimination of congenital syphilis: a comparison of the proposed World Health Organization action plan for the elimination of congenital syphilis with existing national maternal and congenital syphilis policies.Sex Transm Dis. 2007 Jul;34(7 Suppl):S22-30. doi: 10.1097/01.olq.0000261049.84824.40. Sex Transm Dis. 2007. PMID: 17592387 Review.
-
Antibiotic treatment for newborns with congenital syphilis.Cochrane Database Syst Rev. 2019 Feb 15;2(2):CD012071. doi: 10.1002/14651858.CD012071.pub2. Cochrane Database Syst Rev. 2019. PMID: 30776081 Free PMC article.
References
-
- Kimberlin D.W., Barnett E., Lynfield R., Sawyer M.H. Red Book 2021: Report of the Committee on Infectious Diseases. 32nd ed. American Academy of Pediatrics; Itasca, IL, USA: 2021. Syphilis; pp. 729–744.
-
- McDonald R., O’Callaghan K., Torrone E., Barbee L., Grey J., Jackson D., Woodworth K., Olsen E., Ludovic J., Mayes N., et al. Vital Signs: Missed Opportunities for Preventing Congenital Syphilis-United States, 2022. MMWR Morb. Mortal. Wkly Rep. 2023;72:1269–1274. doi: 10.15585/mmwr.mm7246e1. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous